There are other FDA-approved oral weight-loss medications available through a prescription, like phentermine, Contrave , and Qsymia
Mechanistically, it is described as a monoamine reuptake inhibitor, affecting: Dopamine Norepinephrine Serotonin In weight-management trials, its primary investigational role involved: Appetite regulation Reduced caloric intake Altered reward-driven feeding behavior It is not a GLP-1 analog and does not function via incretin pathways
STEP 4 is the important counterpoint: weight came back when treatment stopped, so this is a long-term treatment rather than a short course, and whether it is right for you is a decision for the prescribing doctor
Protein shakes for GLP-1 users can serve double duty as both protein and electrolyte sources when made with the right ingredients
Semaglutide came off the shortage list a year ago, but some companies have continued to provide the drug to patients under exceptions for 'personalised' treatments under a framework known as Section 503A